SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-24-000207
Filing Date
2024-02-07
Accepted
2024-02-07 16:51:55
Documents
18
Period of Report
2024-02-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e5401_8k.htm   iXBRL 8-K 30201
2 EXHIBIT 3.1 e5401_ex3-1.htm EX-3.1 2452
6 GRAPHIC ex3-1_001.jpg GRAPHIC 74824
7 GRAPHIC ex3-1_002.jpg GRAPHIC 231507
8 GRAPHIC ex3-1_003.jpg GRAPHIC 99718
  Complete submission text file 0001731122-24-000207.txt   767177

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE renb-20240201.xsd EX-101.SCH 3024
4 XBRL LABEL FILE renb-20240201_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE renb-20240201_pre.xml EX-101.PRE 22365
19 EXTRACTED XBRL INSTANCE DOCUMENT e5401_8k_htm.xml XML 3740
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 24605008
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)